Speakers: Todd Caldecott, Dip, CI.H., RH (AHG), CAP (NAMA), AAC Psilocybin mushrooms have garnered a lot of interest as new research has picked up from pioneering work done in the 1960s, looking at the use of psychedelics in the treatment and prevention of mental health issues. Todd Caldecott has been working with psychedelics, including psilocybin mushrooms, for two decades, and in 2015, developed a micro-dosing protocol to address severe depression as an effective alternative to conventional antidepressants. This lecture reviews the clinical applications of psilocybin mushrooms, both for macro- and micro-dosing, including a review of the ethnomycology, mycochemistry, pharmacy, clinical application, and dosage, as well as their utility in weaning patients from SSRIs.
Related product: The PowerPoint for this recording is available here: 2024 Southwest Conference on Botanical Medicine: Conference Book Download (PDF)
| Accreditation Board | Credits | Type | Audience |
|---|---|---|---|
| Oregon Board of Naturopathic Medicine (OBNM) | 1.5 | Pharmacy | Naturopathic Doctor (ND) |
| Sonoran University of Health Sciences (SUHS) | 1.5 | Pharmacy | Naturopathic Doctor (ND) |